2010 avoca report executive summary

Click here to load reader

Post on 14-Dec-2014




4 download

Embed Size (px)




  • 1. What Does the Future Hold forClinical Service Provider-Sponsor Relationships?Executive Summary of Results from theAvoca 2010 Industry Survey June 2010
  • 2. CONTENTS Introduction: Objectives of the Industry Survey Methodology Respondents Key Findings Conclusions 2
  • 3. OBJECTIVES OF THE INDUSTRY SURVEY Each year, The Avoca Group polls industry management to understand trends in the outsourcing of clinical research. 2010: How outsourcing relationships are expected to change between the present and 2014. 3
  • 4. OBJECTIVES OF THE INDUSTRY SURVEYQuestions were posed about: Drivers of change in sponsor-clinical service provider relationships Changes companies plan to make to increase the efficiency and quality of outsourced clinical trials Strategies for successful implementation of new outsourcing strategies and tactics How planned changes will impact outsourcing strategies, vendor selection priorities, and the management of outsourcing relationships. 4
  • 5. METHODOLOGY Invitations to participate were emailed to selected executives and managers of sponsor and service provider companies during Q1 2010. Links within the emails directed respondents to the appropriate web-based survey instruments: sponsor perspective provider perspective Respondents who completed the survey were offered an executive summary of the survey results. For questions in which participants were asked to respond on behalf of their companies, only one respondent per company (the most senior) was used in the analysis in order to avoid over-representation of companies with multiple participants. 5
  • 6. RESPONDENTS285 surveys 109 sponsor surveys 73 companies 72% pharmaceutical companies; 22% biotech; 6% other 48% self-described Top 20 70% executive/middle management 174 service provider surveys 88 companies 71% full-service CROs 59% self-described Top 20 79% executive/middle management 6
  • 7. Sponsor Respondent CompaniesAbraxis Bioscience Cardiokine GlaxoSmithkline Orion Pharma Global Alliance for TB DrugAchaogen CareFusion Research Services OSI Pharmaceuticals DevelopmentActavis South Atlantic Celgene Grunenthal OtsukaActelion Celtic Pharma Development Hoffmann-La Roche Pain TherapeuticsActivX Biosciences Chugai Pharma Europe Incyte RatiopharmAdnexus Cognizant Intendis RegeneronAllergan Collins Johnson & Johnson SanofiAllon Therapeutics Cordis Corporation Knopp Neurosciences SantheraAmarin Technologies Coughlan Kowa Research Europe Shire Pharmaceuticals Dainippon Sumitomo PharmaAmgen Lexicon Solvay Pharmaceuticals AmericaAmylin Deltanoid Pharmaceuticals Lilly Teva PharmaceuticalsAstellas Pharma Dey LP Lundbeck TibotecAstraZeneca Eisai MedImmune Vicus TherapeuticsBaxter Endo Merck Wyeth ResearchBayer Schering Pharma Ferring MillenniumBIAL Five Prime Therapeutics Mitsubishi Pharma EuropeBiogen Idec Forest Laboratories NovartisBMS Fresenius Biotech Novo Nordisk Genentech, Member of RocheCadence Pharmaceuticals Ocasio group 7
  • 8. Provider Respondent CompaniesAagami DCL Medical Laboratories KLIXAR QED Clinical ServicesAcurian Eurofins Medinet Kromite LLC QuanticateAepodia Eurotrials Kuantum CRO Quest DiagnosticsAsia Global Research ExecuPharm Laboratorio Hidalgo Quintiles FOCUS Clinical DrugAsiatic Clinical Research LatAm Clinical Trials Radiant Research DevelopmentAverion Forma Life Science Marketing Manipal Acunova Limited RadPharmAxiom Marketing Gagnon Medpace REGISTRATAXIS Clinicals GFA MedPoint Communications ResearchPointAxis Group GVK Biosciences Private Limited MRC RH Bouchard & Associates Ronald Fehst ResearchBeckman Coulter Genomics Harrison Clinical Research Group Myoderm ConsultantsBiomedical Systems Harte Group Ockham RxResearch StaffingC3i i3 Research Omnicare Sariola-HeinerClinForce ICON Paragon Biomedical SQV Clinical Research ServicesClinical Financial Services INC Research PAREXEL Stiris ResearchClinical Research Management IndiPharm Pharma Medica Research TFS Trial Form SupportCogent Performance InsightRx Consulting LLC Pharma Services Network TKL ResearchManagementCOMSYS Clinical Integrium PharmaNet TooneConsentSolutions invivodata PharmaWrite US OncologyCovance IRB SERVICES Pharm-Olam Vantage BioTrialsCRS Clinical Research Services Iris PPD VirtualScopicsCyncron John R Vogel Associates PRA Woodley Equipment CompanyDatatrial Kendle PSI ZeeCRO 8
  • 9. Key Findings
  • 10. Sponsor Data 10 15 20 25 30 35 40 45 50 0 5 Better measurement of provider performance